These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 2390646

  • 1. Graft-versus-leukemia in bone marrow transplantation. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Gale RP, Horowitz MM.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():94-7. PubMed ID: 2390646
    [Abstract] [Full Text] [Related]

  • 2. Graft-versus-leukemia reactions after bone marrow transplantation.
    Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B.
    Blood; 1990 Feb 01; 75(3):555-62. PubMed ID: 2297567
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Feb 01; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 01; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 5. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N, Badsberg JH, Lönnqvist B, Ringdén O, Volin L, Rajantie J, Nikoskelainen J, Keiding N.
    Bone Marrow Transplant; 1990 Jun 01; 5(6):413-8. PubMed ID: 2164434
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E, Nagler A, Or R, Kapelushnik J, Slavin S.
    Clin Transpl; 1996 Jun 01; ():281-90. PubMed ID: 9286578
    [Abstract] [Full Text] [Related]

  • 7. Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.
    McGlave P.
    Semin Hematol; 1990 Jul 01; 27(3 Suppl 4):23-30. PubMed ID: 1695763
    [Abstract] [Full Text] [Related]

  • 8. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Ringdén O, Horowitz MM.
    Transplant Proc; 1989 Feb 01; 21(1 Pt 3):2989-92. PubMed ID: 2650409
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J, Ringdén O.
    Clin Transplant; 1994 Jun 01; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [Abstract] [Full Text] [Related]

  • 10. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR.
    Biol Blood Marrow Transplant; 2001 Jun 01; 7(11):620-30. PubMed ID: 11760150
    [Abstract] [Full Text] [Related]

  • 11. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K, Downs K, Ashby M, Dodds A, Concannon A, Biggs J.
    Bone Marrow Transplant; 1989 Jan 01; 4(1):23-7. PubMed ID: 2647183
    [Abstract] [Full Text] [Related]

  • 12. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
    Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F.
    Bone Marrow Transplant; 1999 Mar 01; 23(5):443-50. PubMed ID: 10100557
    [Abstract] [Full Text] [Related]

  • 13. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia.
    Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NK, Rowlings PA, Weisdorf DJ, Zhang MJ, Barrett AJ.
    Bone Marrow Transplant; 1998 Jan 01; 21(2):153-8. PubMed ID: 9489632
    [Abstract] [Full Text] [Related]

  • 14. Graft-versus-leukemia following bone marrow transplantation.
    Butturini A, Bortin MM, Gale RP.
    Bone Marrow Transplant; 1987 Oct 01; 2(3):233-42. PubMed ID: 3332173
    [Abstract] [Full Text] [Related]

  • 15. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L, Lubin I, Factorowich I, Lapidot Z, Reich S, Reisner Y, Slavin S.
    J Immunol; 1994 Sep 15; 153(6):2562-7. PubMed ID: 8077666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
    Devergie A, Reiffers J, Vernant JP, Herve P, Guyotat D, Maraninchi D, Rio B, Michallet M, Jouet JP, Milpied N.
    Bone Marrow Transplant; 1990 Jun 15; 5(6):379-86. PubMed ID: 2088319
    [Abstract] [Full Text] [Related]

  • 19. T cell depletion in bone marrow transplantation for leukemia: current results and future directions.
    Butturini A, Gale RP.
    Bone Marrow Transplant; 1988 May 15; 3(3):185-92. PubMed ID: 3048485
    [Abstract] [Full Text] [Related]

  • 20. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
    Carlens S, Ringdén O, Aschan J, Hägglund H, Ljungman P, Mattsson J, Remberger M.
    Clin Transplant; 1998 Apr 15; 12(2):84-92. PubMed ID: 9575394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.